NASDAQ: ASMBAssembly Biosciences Inc Stock Ownership - Who owns Assembly Biosciences?
Insider buying vs selling
Have Assembly Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jeanette M. Bjorkquist | Principal Accounting Officer | 2025-03-31 | 180 | $9.85 | $1.77kSell |
| John G. McHutchison | Director | 2025-03-31 | 757 | $9.85 | $7.45kSell |
| Jason A. Okazaki | CEO and President | 2025-03-31 | 355 | $9.85 | $3.50kSell |
| Nicole S. White | Chief Manufacturing Officer | 2025-03-31 | 197 | $9.85 | $1.94kSell |
| Michael Houghton | Director | 2024-12-30 | 3,202 | $15.61 | $50.00kBuy |
| Gilead Sciences Inc | 10% Owner | 2024-12-19 | 940,499 | $21.37 | $20.10MBuy |
ASMB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ASMB insiders and whales buy or sell their stock.
ASMB Shareholders
What type of owners hold Assembly Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gilead Sciences Inc | 28.48% | 4,505,391 | $157.69M | Insider |
| Gilead Sciences Inc | 28.48% | 4,505,391 | $157.69M | Institution |
| Ecor1 Capital Fund Qualified LP | 13.67% | 2,162,029 | $75.67M | Insider |
| Alexander Schornstein | 11.58% | 1,832,405 | $64.13M | Insider |
| Adam Zlotnick | 8.35% | 1,321,009 | $46.24M | Insider |
| Farallon Capital Management LLC | 7.76% | 1,227,590 | $42.97M | Institution |
| Ra Capital Management LP | 6.45% | 1,020,410 | $35.71M | Institution |
| Commodore Capital LP | 6.32% | 1,000,000 | $35.00M | Institution |
| Derek A. Small | 5.24% | 828,791 | $29.01M | Insider |
| Janus Henderson Group PLC | 4.76% | 752,626 | $26.34M | Institution |
ASMB vs Biotech Stocks
Assembly Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.